{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:16:42Z","timestamp":1790396202969,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1596,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Physiol."],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/jcp.22503","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T17:22:47Z","timestamp":1289409767000},"page":"1741-1749","source":"Crossref","is-referenced-by-count":110,"title":["Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells"],"prefix":"10.1002","volume":"226","author":[{"given":"Marcia","family":"Godinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddy","family":"Setyono-Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert C.J.","family":"Dorssers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"van Agthoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"10.1002\/jcp.22503-BIB1|cit1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000258493","article-title":"Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer","volume":"77","author":"Arpino","year":"2009","journal-title":"Oncology"},{"issue":"7","key":"10.1002\/jcp.22503-BIB2|cit2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcp.22503-BIB3|cit3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0960-0760(92)90182-I","article-title":"Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2\/neu amplification","volume":"43","author":"Berns","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1002\/jcp.22503-BIB4|cit4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-1119(94)00534-Y","article-title":"Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment","volume":"159","author":"Berns","year":"1995","journal-title":"Gene"},{"key":"10.1002\/jcp.22503-BIB5|cit5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/332459a0","article-title":"Human gene expression first occurs between the four- and eight-cell stages of preimplantation development","volume":"332","author":"Braude","year":"1988","journal-title":"Nature"},{"key":"10.1002\/jcp.22503-BIB6|cit6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10549-009-0403-4","article-title":"The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells","volume":"120","author":"Brinkman","year":"2010","journal-title":"Breast cancer Res Treat"},{"key":"10.1002\/jcp.22503-BIB7|cit7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1191","article-title":"New tools for functional mammalian cancer genetics","volume":"3","author":"Brummelkamp","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcp.22503-BIB8|cit8","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/sj.onc.1206937","article-title":"Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling","volume":"22","author":"Clarke","year":"2003","journal-title":"Oncogene"},{"key":"10.1002\/jcp.22503-BIB9|cit9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<700::AID-IJC24>3.0.CO;2-D","article-title":"Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells","volume":"72","author":"Dorssers","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1002\/jcp.22503-BIB10|cit10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1210\/me.7.7.870","article-title":"Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: Identification of bcar-1, a common integration site","volume":"7","author":"Dorssers","year":"1993","journal-title":"Mol Endocrinol"},{"key":"10.1002\/jcp.22503-BIB11|cit11","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/bcr954","article-title":"Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor pathway","volume":"7","author":"Dorssers","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1002\/jcp.22503-BIB12|cit12","first-page":"8452","article-title":"HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer","volume":"61","author":"Dowsett","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.22503-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: An overview of the randomised trials","volume":"351","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/jcp.22503-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jcp.22503-BIB15|cit15","first-page":"3832","article-title":"Prediction of relapse and survival in breast cancer patients by pS2 protein status","volume":"50","author":"Foekens","year":"1990","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.22503-BIB16|cit16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1200\/JCO.1993.11.5.899","article-title":"Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: Multivariate analysis","volume":"11","author":"Foekens","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.22503-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0093-691X(01)00481-2","article-title":"The maternal legacy to the embryo: Cytoplasmic components and their effects on early development","volume":"55","author":"Gandolfi","year":"2001","journal-title":"Theriogenology"},{"issue":"2","key":"10.1002\/jcp.22503-BIB18|cit18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1097-2765(03)00048-0","article-title":"The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors","volume":"11","author":"Garrett","year":"2003","journal-title":"Mol Cell"},{"key":"10.1002\/jcp.22503-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/sj.bjc.6605884","article-title":"Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer","volume":"103","author":"Godinho","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1002\/jcp.22503-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000087282","article-title":"Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women","volume":"69","author":"Gradishar","year":"2005","journal-title":"Oncology"},{"key":"10.1002\/jcp.22503-BIB21|cit21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","article-title":"c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes","volume":"63","author":"Gullick","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1002\/jcp.22503-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.22503-BIB23|cit23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-4827(02)00099-X","article-title":"The ErbB receptors and their role in cancer progression","volume":"284","author":"Holbro","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1002\/jcp.22503-BIB24|cit24","article-title":"Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines","author":"Hollestelle","year":"2009","journal-title":"Breast Cancer Res Treat."},{"key":"10.1002\/jcp.22503-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(17)38062-6","article-title":"Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor","volume":"253","author":"Horwitz","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.22503-BIB26|cit26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nature07483","article-title":"Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen","volume":"456","author":"Hurtado","year":"2008","journal-title":"Nature"},{"key":"10.1002\/jcp.22503-BIB27|cit27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: The complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcp.22503-BIB28|cit28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-I): A randomised prevention trial","volume":"360","author":"IBIS Investigators","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/jcp.22503-BIB29|cit29","first-page":"3723","article-title":"Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors","volume":"57","author":"Johnston","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.22503-BIB30|cit30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2005.04.008","article-title":"Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release","volume":"239","author":"Kansra","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1002\/jcp.22503-BIB31|cit31","doi-asserted-by":"crossref","first-page":"14027","DOI":"10.1073\/pnas.0603227103","article-title":"The transcriptome of human oocytes","volume":"103","author":"Kocabas","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jcp.22503-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/ijc.22423","article-title":"Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells","volume":"120","author":"Liu","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/jcp.22503-BIB33|cit33","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1093\/nar\/10.24.7895","article-title":"Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line","volume":"10","author":"Masiakowski","year":"1982","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/jcp.22503-BIB34|cit34","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1677\/erc.1.01273","article-title":"Resistance to endocrine therapy in breast cancer: Exploiting estrogen receptor\/growth factor signaling crosstalk","volume":"13","author":"Massarweh","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/jcp.22503-BIB35|cit35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1541-7786.MCR-05-0156","article-title":"Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells","volume":"4","author":"Meijer","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1002\/jcp.22503-BIB36|cit36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1933719108322425","article-title":"Profiling gene expression in human placentae of different gestational ages: An OPRU Network and UW SCOR Study","volume":"15","author":"Mikheev","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1002\/jcp.22503-BIB37|cit37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jsbmb.2007.05.013","article-title":"Aromatase inhibitors-Gene discovery","volume":"106","author":"Miller","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1002\/jcp.22503-BIB38|cit38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/pd.608","article-title":"Identification of expressed sequence tags preferentially expressed in human placentas by in silico subtraction","volume":"23","author":"Miner","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1002\/jcp.22503-BIB39|cit39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","article-title":"Biological determinants of endocrine resistance in breast cancer","volume":"9","author":"Musgrove","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcp.22503-BIB40|cit40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.placenta.2006.05.010","article-title":"Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia","volume":"28","author":"Nishizawa","year":"2007","journal-title":"Placenta"},{"key":"10.1002\/jcp.22503-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","article-title":"Tamoxifen in the treatment of breast cancer","volume":"339","author":"Osborne","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/jcp.22503-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.03.016","article-title":"Pathways to tamoxifen resistance","volume":"256","author":"Riggins","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1002\/jcp.22503-BIB43|cit43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bjc.1996.2","article-title":"Oestrogen receptor: A stable phenotype in breast cancer","volume":"73","author":"Robertson","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1002\/jcp.22503-BIB44|cit44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1126\/science.1140693","article-title":"The maternal-zygotic transition: Death and birth of RNAs","volume":"316","author":"Schier","year":"2007","journal-title":"Science"},{"key":"10.1002\/jcp.22503-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.1993.11.10.1936","article-title":"Clinical significance of HER-2\/neu oncogene amplification in primary breast cancer","volume":"11","author":"Seshadri","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.22503-BIB46|cit46","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1158\/1078-0432.CCR-05-0560","article-title":"How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: A retrospective study","volume":"11","author":"Sieuwerts","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcp.22503-BIB47|cit47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of HER2\/neu oncogene","volume":"235","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1002\/jcp.22503-BIB48|cit48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2130","article-title":"New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast","volume":"211","author":"Speirs","year":"2007","journal-title":"J Pathol"},{"key":"10.1002\/jcp.22503-BIB49|cit49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-213X-7-125","article-title":"Differential regulation of abundance and deadenylation of maternal transcripts during bovine oocyte maturation in vitro and in vivo","volume":"7","author":"Thelie","year":"2007","journal-title":"BMC Dev Biol"},{"key":"10.1002\/jcp.22503-BIB50|cit50","first-page":"5082","article-title":"Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells","volume":"52","author":"Van Agthoven","year":"1992","journal-title":"Cancer Res"},{"key":"10.1002\/jcp.22503-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/me.8.11.1474","article-title":"Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations","volume":"8","author":"Van Agthoven","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1002\/jcp.22503-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/emboj\/17.10.2799","article-title":"Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells","volume":"17","author":"Van Agthoven","year":"1998","journal-title":"EMBO J"},{"key":"10.1002\/jcp.22503-BIB53|cit53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2008.17.1462","article-title":"Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance","volume":"27","author":"Van Agthoven","year":"2009a","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcp.22503-BIB54|cit54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-008-9969-5","article-title":"Functional identification of genes causing estrogen independence of human breast cancer cells","volume":"114","author":"Van Agthoven","year":"2009b","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcp.22503-BIB55|cit55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1677\/ERC-09-0062","article-title":"Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response","volume":"17","author":"Van Agthoven","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/jcp.22503-BIB56|cit56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jnci\/95.2.160","article-title":"Italian randomized trial among women with hysterectomy: Tamoxifen and hormone-dependent breast cancer in high-risk women","volume":"95","author":"Veronesi","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jcp.22503-BIB57|cit57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2007.05.009","article-title":"Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer","volume":"106","author":"Walker","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jcp.22503-BIB58|cit58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.2648","article-title":"The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: A retrospective of the last decade","volume":"220","author":"Weigelt","year":"2010","journal-title":"J Pathol"},{"key":"10.1002\/jcp.22503-BIB59|cit59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/bjc.1992.22","article-title":"Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer","volume":"65","author":"Wright","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1002\/jcp.22503-BIB60|cit60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1002\/jcp.22503-BIB61|cit61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.fertnstert.2006.07.1509","article-title":"Distinct sets of developmentally regulated genes that are expressed by human oocytes and human embryonic stem cells","volume":"87","author":"Zhang","year":"2007","journal-title":"Fertil Steril"}],"container-title":["Journal of Cellular Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcp.22503","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcp.22503\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T10:05:47Z","timestamp":1636797947000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcp.22503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1002\/jcp.22503","relation":{},"ISSN":["0021-9541"],"issn-type":[{"value":"0021-9541","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}